US$ 29.61
what is a glp-1 antagonist Glucagon-like peptide-1 GLP-1 Agonists - What is
Description
Review the MOTS-C side effects page for the most current safety information available

Serrya, M
When it is taken with diabetes medications, particularly insulin and insulin secretagogues, the risk of hypoglycemia is increased

Coagonist of GLP-1 and Gcg receptor ameliorates development of non-alcoholic fatty liver disease

doi: 10.2337/db08-0872

Mechanism of Gly-Pro-pNA cleavage catalyzed by dipeptidyl peptidase-IV and its inhibition by saxagliptin (BMS-477118)
